Pro Medicus Valuation
| PME Stock | 221.75 7.13 3.32% |
At this time, the company appears to be undervalued. Pro Medicus holds a recent Real Value of USD232.74 per share. The prevailing price of the company is USD221.75. Our model determines the value of Pro Medicus from analyzing the company fundamentals such as Shares Outstanding of 104.5 M, return on equity of 0.51, and Operating Margin of 0.73 % as well as examining its technical indicators and probability of bankruptcy.
Price Book 123.4372 | Enterprise Value 23 B | Enterprise Value Ebitda 190.735 | Price Sales 143.483 | Forward PE 208.3333 |
Undervalued
Today
Please note that Pro Medicus' price fluctuation is very steady at this time. Calculation of the real value of Pro Medicus is based on 3 months time horizon. Increasing Pro Medicus' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Pro Medicus' intrinsic value may or may not be the same as its current market price of 221.75, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 221.75 | Real 232.74 | Hype 222.73 | Naive 225.43 |
The intrinsic value of Pro Medicus' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Pro Medicus' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Pro Medicus helps investors to forecast how Pro stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Pro Medicus more accurately as focusing exclusively on Pro Medicus' fundamentals will not take into account other important factors: Pro Medicus Cash |
|
Pro Medicus Total Value Analysis
Pro Medicus is at this time forecasted to have takeover price of 23.02 B with market capitalization of 23.17 B, debt of 2.07 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Pro Medicus fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
23.02 B | 23.17 B | 2.07 M |
Pro Medicus Investor Information
About 51.0% of the company outstanding shares are owned by corporate insiders. The company last dividend was issued on the 4th of September 2024. Based on the key indicators related to Pro Medicus' liquidity, profitability, solvency, and operating efficiency, Pro Medicus is performing exceptionally good at this time. It has a great odds to report excellent financial results in December.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 91.1 M | 86.8 M |
|
|
Pro Medicus Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Pro Medicus has an asset utilization ratio of 62.74 percent. This implies that the Company is making USD0.63 for each dollar of assets. An increasing asset utilization means that Pro Medicus is more efficient with each dollar of assets it utilizes for everyday operations.Pro Medicus Ownership Allocation
Pro Medicus owns a total of 104.5 Million outstanding shares. Pro Medicus has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Pro Medicus Profitability Analysis
The company reported the revenue of 161.5 M. Net Income was 82.79 M with profit before overhead, payroll, taxes, and interest of 126.79 M.About Pro Medicus Valuation
The stock valuation mechanism determines Pro Medicus' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Pro Medicus based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pro Medicus. We calculate exposure to Pro Medicus's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Pro Medicus's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 122.3 M | 128.4 M |
Pro Medicus Quarterly Retained Earnings |
|
Additional Tools for Pro Stock Analysis
When running Pro Medicus' price analysis, check to measure Pro Medicus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pro Medicus is operating at the current time. Most of Pro Medicus' value examination focuses on studying past and present price action to predict the probability of Pro Medicus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pro Medicus' price. Additionally, you may evaluate how the addition of Pro Medicus to your portfolios can decrease your overall portfolio volatility.